Cerebral amyloid angiopathy: Both viper and maggot in the brain

Annals of Neurology

Volumn 58, Issue 3, 2005, Pages 348-350

  Weller, Roy O ^a   Nicoll, James A R ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

AGING; ALZHEIMER DISEASE; APOE GENE; BASEMENT MEMBRANE; BRAIN HEMORRHAGE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; EDITORIAL; GENE; GENETIC POLYMORPHISM; HUMAN; IMMUNIZATION; INTERSTITIAL FLUID; NEUROPATHOLOGY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; TRANSGENIC MOUSE; VASCULAR AMYLOIDOSIS;

AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; CEREBRAL AMYLOID ANGIOPATHY; HUMANS;

EID: 24644520288     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20622     Document Type: Editorial

References (25)

1. Rensink AAM, de Waal RMW, Kremer B, et al. Pathogenesis of cerebral amyloid angiopathy. Brain Res Rev 2003;43: 207-223.
2. Revesz T, Ghiso J, Lashley T, et al. Cerebral amyloid angiopathies: a pathologic, biochemical, and genetic view. J Neuropathol Exp Neurol 2003;62:885-898.
3. Rosand J, Muzikansky A, Kumar A, et al. Spatial clustering of hemorrhages in cerebral amyloid angiopathy. Ann Neurol 2005; 58:459-462.
4. Nicoll JAR, Yamada M, Frackowiak J, et al. Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 2004; 25:589-597.
5. Calhoun ME, Burgermeister P, Phinney AL, et al. Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid. Proc Natl Acad Sci USA 1999;96:14088-14093.
6. Herzig MC, Winkler DT, Burgermeister P, et al. Aβ is targeted to the vasculature in a mouse model of hereditary cerebral hemorrhage with amyloidosis. Nat Neurosci 2004;7:954-960.
7. Weller RO, Massey A, Newman TA, et al. Cerebral amyloid angiopathy: amyloid beta accumulares in putative interstitial fluid drainage pathways in Alzheimer's disease. Am J Pathol 1998;153:725-733.
8. Preston S D, Steart PV, Wilkinson A, et al. Capillary and arterial amyloid angiopathy: delineation of the perivascular route for elimination of amyloid-beta from the human brain. Neuropathol Appl Neurobiol 2003;29:106-117.
9. Weller RO, Nicoll JAR. Cerebral amyloid angiopathy: pathogenesis and effects on the ageing and Alzheimer brain. Neurol Res 2003;25:611-616.
10. Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int 2004;45:545-552.
11. Carare-Nnadi R, Bernardes-Silva M, Subash M, et al. Perivascular pathways for the clearance of interstitial fluid from the brain and the pathology of Alzheimer's disease. Neuropathol Appl Neurobiol 2005;31:218.
12. Cserr HF, Harling Berg C, Ichimura T, et al. Drainage of cerebral extracellular fluids into cervical lymph: an afferent limb in brain/immune system interactions. Fernstrom Found Ser 1990;14:413-420.
13. Weller RO, Massey A, Kuo YM, et al. Cerebral amyloid angiopathy: accumulation of A beta in interstitial fluid drainage pathways in Alzheimer's disease. Ann NY Acad Sci 2000;903: 110-117.
14. Wisniewski HM, Wegiel J. Beta-amyloid formation by myocytes of leptomeningeal vessels. Acta Neuropathol (Berl) 1994; 87:233-241.
15. Lue LF, Kuo YM, Roher AE, et al. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 1999;155:853-862.
16. McLean CA, Cherny RA, Fraser FW, et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneracion in Alzheimer's disease. Ann Neurol 1999;46:860-866.
17. Roher AE, Kuo Y-M, Esh C, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med 2003;9:112-122.
18. Schley D, Carare-Nnadi R, Please CP, et al. Mechanisms to explain the reverse perivascular transport of solutes out of the brain. J Theor Biol (in press).
19. Yow HY, Weller RO. A role for cerebrovascular disease in determining the pattern of beta amyloid deposition in Alzheimer's disease. Neuropachol Appl Neurobiol 2002;28:149.
20. Roher AE, Esh C, Kokjohn TA, et al. Circle of Willis atherosclerosis is a risk factor for sporadic Alzheimer's disease. Arterioscler Thromb Vasc Biol 2003;23:2055-2062.
21. Nicoll JA, McCarron MO. APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid 2001;8(suppl 1):51-55.
22. Nicoll JA, Burnett C, Love S, et al. High frequency of apolipoprotein E epsilon 2 in patients with cetebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1996;39: 682-683.
23. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-177.
24. Nicoll JA, Wilkinson D, Holmes C, et al. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003;9:448-452.
25. Wilcock DM, Rojiani A, Rosenthal A, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation 2004;1:24.